---

title: 'Cystitis and Pyelonephritis in Women'
authors:
    - 'Michelle Lin, MD'
created: 2011/09/02
updates: null
categories:
    - Infectious Disease
    - Genitourinary
drugs: 'nitrofurantoin, sulfamethoxazole, fosfomycin, pivmecillinam, ofloxacin, ciprofloxacin, levofloxacin, amoxicillin-clavulanate, cefdinir, cefaclor, cefpodoxime-proxetil, trimethoprim-sulfamethoxazole'

---





# Antibiotic Selection for Cystitis and Pyelonephritis in Women
*2010 Infectious Disease Society of America (IDSA) and European Society for Microbiology and Infectious Diseases (ESMID) guidelines*

**Target population**
- Acute, uncomplicated cystitis and pyelonephritis in women 
- Premenopausal, non-pregnant women without known urological abnormalities or co-morbidities (i.e. DM)

## Acute uncomplicated cystitis

1. **<span class="drug">Nitrofurantoin</span>** (100 mg PO BID x 5 days)

2. **<span class="drug">Trimethoprim</span>-sulfamethoxazole** (1 DS tab PO BID x 3 days)

  - Rising resistance rates
  - Only give if local antibiogram shows &lt;20% resistance

3. **<span class="drug">Fosfomycin</span>** (3 gm PO x 1) 

  - Slightly less efficiacy compared to standard short-course regimens 

4. **<span class="drug">Pivmecillinam</span>** (400 mg PO BID x 3-7 days) 

  - Only available in Europe

5. **Fluoroquinolones** (3-day course of **<span class="drug">ofloxacin</span>**, **<span class="drug">ciprofloxacin</span>**, or **<span class="drug">levofloxacin</span>**) 

  - Avoid if possible to minimize selection of drug-resistant organisms

**Beta-lactams** (3-7 day course of **<span class="drug">amoxicillin-clavulanate</span>**, **<span class="drug">cefdinir</span>**, **<span class="drug">cefaclor</span>**, **<span class="drug">cefpodoxime-proxetil)</span>**

  - Avoid if possible to minimize selection of drug-resistant organisms
  - Inferior efficacy compared with standard regimens
  - **<span class="drug">Cephalexin</span>** less well studied

## Acute Pyelonephritis

Urine analysis and urine culture should always be performed 

**<span class="drug">Ciprofloxacin</span>** (500 mg po BID x 7 days) +/- **<span class="drug">ciprofloxacin</span>** 400 mg IV x 1 dose
If **&gt;10% resistance to fluoroquinolones**, give 1-time IV dose:
-   **<span class="drug">Ceftriaxone</span>** 1 gm IV, or 
-   An aminoglycoside 

If **&lt;10% resistance rate,** alternative oral fluoroquinolone outpatient dosing options: 
-   **<span class="drug">Ciprofloxacin</span>** XR 1000 mg po daily x 7 days, or
-   **<span class="drug">Levofloxacin</span>** 750 mg po daily x 5 days 

**<span class="drug">Trimethoprim-sulfamethoxazole</span>** (1 tab DS PO BID x 14 days)
1.  If resistance rate unknown, give 1-time dose of **<span class="drug">Ceftriaxone</span>** 1 gm IV or aminoglycoside first

** Beta-lactams** (10-14 day course)
1.  Because of less efficacy, give 1-time dose of **<span class="drug">Ceftriaxone</span>** 1 gm IV or aminoglycoside first 

## References

-   [Gupta K et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the IDSA and the ESMID. Clin Infect Dis. 2011; 52(5).](https://www.ncbi.nlm.nih.gov/pubmed/10589881)
